Kathy Yi
2021
In 2021, Kathy Yi earned a total compensation of $3.5M as Former Chief Financial Officer at Cerevel Therapeutics Holdings.
Compensation breakdown
| Option Awards | $2,720,766 |
|---|---|
| Salary | $384,710 |
| Other | $395,693 |
| Total | $3,501,169 |
Yi received $2.7M in option awards, accounting for 78% of the total pay in 2021.
Yi also received $384.7K in salary and $395.7K in other compensation.
Rankings
In 2021, Kathy Yi's compensation ranked 3,826th out of 12,415 executives tracked by ExecPay. In other words, Yi earned more than 69.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,826 out of 12,415 | 69th |
Division Manufacturing | 1,567 out of 5,505 | 72nd |
Major group Chemicals And Allied Products | 639 out of 2,375 | 73rd |
Industry group Drugs | 568 out of 2,096 | 73rd |
Industry Pharmaceutical Preparations | 397 out of 1,546 | 74th |
Source: SEC filing on April 28, 2022.
Yi's colleagues
We found five more compensation records of executives who worked with Kathy Yi at Cerevel Therapeutics Holdings in 2021.
2021
N Coles
Cerevel Therapeutics Holdings
Chief Executive Officer
2021
Abraham Ceesay
Cerevel Therapeutics Holdings
President
2021
Raymond Sanchez
Cerevel Therapeutics Holdings
Chief Medical Officer
2021
Scott Akamine
Cerevel Therapeutics Holdings
Chief Legal Officer
2021
Mark Bodenrader
Cerevel Therapeutics Holdings